$AUPH
Aurinia Pharmaceuticals Inc. Stock $auph

$auph Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000160062024000108 Filed on November 07, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$67.77M
YoY Change		24.32%
Cost Of Revenue		$6.035M
YoY Change		-10.84%
Gross Profit		$61.74M
YoY Change		29.3%
Gross Profit Margin		91.1%
Selling, General & Admin		$42.37M
YoY Change		-11.29%
% of Gross Profit		68.63%
Research & Development		$3.047M
YoY Change		-77.6%
% of Gross Profit		4.94%
Depreciation & Amortization		$4.893M
YoY Change		-10.38%
% of Gross Profit		7.93%
Operating Expenses		$3.047M
YoY Change		-77.6%
Operating Profit		$11.75M
YoY Change		-172.24%
Interest Expense		$3.059M
YoY Change		118.5%
% of Operating Profit		26.04%
Other Income/Expense, Net
YoY Change
Pretax Income		$14.81M
YoY Change		-212.61%
Income Tax		$500.0K
% Of Pretax Income		3.38%
Net Earnings		$14.35M
YoY Change		-206.72%
Net Earnings / Revenue		21.17%
Basic Earnings Per Share		$0.10
Diluted Earnings Per Share		$0.10
COMMON SHARES
Basic Shares Outstanding	143.2M shares	143.0M shares
Diluted Shares Outstanding		145.7M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$348.2M
YoY Change		3.3%
Cash & Equivalents		$36.63M
Short-Term Investments		$311.6M
Other Short-Term Assets		$2.700M
YoY Change		64.13%
Inventory		$38.71M
Prepaid Expenses
Receivables		$36.48M
Other Receivables		$0.00
Total Short-Term Assets		$440.5M
YoY Change		3.28%
LONG-TERM ASSETS
Property, Plant & Equipment		$2.887M
YoY Change		-17.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$0.00
YoY Change		-100.0%
Other Assets		$868.0K
YoY Change		-42.82%
Total Long-Term Assets		$108.9M
YoY Change		-15.28%
TOTAL ASSETS
Total Short-Term Assets		$440.5M
Total Long-Term Assets		$108.9M
Total Assets		$549.4M
YoY Change		-1.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$8.878M
YoY Change		-0.25%
Accrued Expenses		$47.90M
YoY Change		8.38%
Deferred Revenue		$4.304M
YoY Change		-7.68%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$14.93M
YoY Change		12.23%
Total Short-Term Liabilities		$78.61M
YoY Change		6.39%
LONG-TERM LIABILITIES
Long-Term Debt		$65.96M
YoY Change		-8.65%
Other Long-Term Liabilities		$10.80M
YoY Change		4.45%
Total Long-Term Liabilities		$10.80M
YoY Change		4.45%
TOTAL LIABILITIES
Total Short-Term Liabilities		$78.61M
Total Long-Term Liabilities		$10.80M
Total Liabilities		$161.4M
YoY Change		-1.09%
SHAREHOLDERS EQUITY
Retained Earnings		-$938.0M
YoY Change		2.46%
Common Stock		$119.8M
YoY Change		9.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$388.0M
YoY Change
Total Liabilities & Shareholders Equity		$549.4M
YoY Change		-1.02%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$14.35M
YoY Change		-206.72%
Depreciation, Depletion And Amortization		$4.893M
YoY Change		-10.38%
Cash From Operating Activities		$17.03M
YoY Change		-228.33%
INVESTING ACTIVITIES
Capital Expenditures		$129.0K
YoY Change		-261.25%
Acquisitions
YoY Change
Other Investing Activities		-$10.44M
YoY Change		-47.2%
Cash From Investing Activities		-$10.57M
YoY Change		-46.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-2.722M
YoY Change		16.82%
NET CHANGE
Cash From Operating Activities		17.03M
Cash From Investing Activities		-10.57M
Cash From Financing Activities		-2.722M
Net Change In Cash		3.735M
YoY Change		-110.58%
FREE CASH FLOW
Cash From Operating Activities		$17.03M
Capital Expenditures		$129.0K
Free Cash Flow		$16.90M
YoY Change		-228.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001600620
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address City Or Town EntityAddressCityOrTown	Edmonton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	AB
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	T5L 4S6
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1231763
	dei	City Area Code CityAreaCode	(250)
	dei	Local Phone Number LocalPhoneNumber	744-2487
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
	us-gaap	Depreciation Depreciation	14583000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	8836000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	33543000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-991000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	12000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	934000	usd
	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	44000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46397000	usd
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	348747000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	583000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1249000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Z4
	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	108715000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10900000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143353000	shares
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2645000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37142000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4672000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5190000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1018000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	989000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	78609000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10911000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	77188000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q3	us-gaap	Liabilities Liabilities	161359000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-937999000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	170108000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1206613000	usd
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1200218000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-942322000	usd
	dei	Entity Address Address Line1 EntityAddressAddressLine1	#140, 14315 - 118 Avenue
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	36483000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	24089000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1517000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5951000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6530000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10844000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	350416000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	74000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	1000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	350489000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost	350616000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	75000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses	1000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	350690000	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	500000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	700000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	500000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	300000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000	usd
	dei	Entity Registrant Name EntityRegistrantName	Aurinia Pharmaceuticals Inc.
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	143179269	shares
	dei	Security12b Title Security12bTitle	Common shares, no par value
	dei	Trading Symbol TradingSymbol	AUPH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37142000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48875000	usd
CY2024Q3	us-gaap	Debt Securities Current DebtSecuritiesCurrent	311605000	usd
CY2023Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	301614000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	38714000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	39705000	usd
CY2024Q3	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	13815000	usd
CY2023Q4	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	9486000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2700000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1031000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	440459000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	424800000	usd
CY2023Q4	us-gaap	Debt Securities Noncurrent DebtSecuritiesNoncurrent	201000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2887000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4509000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4977000	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	96459000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4498000	usd
CY2024Q3	us-gaap	Assets Assets	549361000	usd
CY2023Q4	us-gaap	Assets Assets	548062000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56770000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	14609000	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	143109000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	143833000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	143833000	shares
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	388002000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	377954000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	549361000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	548062000	usd
CY2024Q3	us-gaap	Debt Securities Noncurrent DebtSecuritiesNoncurrent	0	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	868000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3354000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4179000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	54389000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4304000	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	143109000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	143109000	shares
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	120788000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-385000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	175266000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-730000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	130418000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54515000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	6769000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	22696000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8753000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42367000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47759000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	134996000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	144964000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3047000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4813000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1590000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2388000	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	14927000	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	65955000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	75479000	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	143109000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	143109000	shares
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	119773000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67771000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54515000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	130418000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	6035000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	6769000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	22696000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8753000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42367000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47759000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	134996000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	144964000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3047000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13605000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12678000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39413000	usd
CY2024Q3	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q3	us-gaap	Restructuring Costs RestructuringCosts	0	usd
	us-gaap	Restructuring Costs RestructuringCosts	7755000	usd
	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2024Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4574000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	70778000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	457000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	178284000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	192435000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3018000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62017000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1400000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3689000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1465000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4267000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4514000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12982000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12429000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14807000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13149000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6275000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51053000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1952000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13447000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67771000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	175266000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	130418000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	6035000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	6769000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	22696000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8753000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42367000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47759000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	134996000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	144964000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3047000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13605000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12678000	usd
	us-gaap	Restructuring Costs RestructuringCosts	7755000	usd
	us-gaap	Restructuring Costs RestructuringCosts	0	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	695000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	192435000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3018000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62017000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1208000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1400000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1465000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4267000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4514000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12982000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12429000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14807000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13149000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	457000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1952000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13447000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
CY2024Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	474000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	73000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	345000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	114000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4668000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142847000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143353000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143085000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145651000	shares
	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	11864000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	240000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-449000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8959000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3482000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3929000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26046000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11733000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47775000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37142000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46397000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	3559000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1459000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36630000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.25
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	36500000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	24100000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12678000	usd
CY2023Q3	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2024Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4574000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-159000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	56023000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	192435000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	11748000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143051000	shares
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16263000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3018000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62017000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3689000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1465000	usd
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4267000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4514000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12982000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14807000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13149000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6275000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51053000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	457000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1952000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13447000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	0	usd
CY2023Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	73000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	345000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	114000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14824000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13374000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4668000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51031000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142847000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143353000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145651000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142847000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145010000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143085000	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	364616000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	235000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	474000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	73000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	114000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14824000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13374000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4668000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142847000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143353000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145651000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142847000	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	364616000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8327000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	474000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	388002000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	392292000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1151000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11808000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	73000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13447000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	391877000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	377954000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	18619000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	703000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22650000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	345000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	388002000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	405435000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3024000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33543000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	114000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	391877000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22650000	usd
	auph	Foreign Translation On Finance Lease Liability ForeignTranslationOnFinanceLeaseLiability	1335000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	24463000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6001000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2889000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11812000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-550000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-499000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47773000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	391287000	usd
	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	11864000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	419000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143085000	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	364616000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8327000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	474000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	388002000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	392292000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1151000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11808000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	377954000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	646000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	18619000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	703000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22650000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	345000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	388002000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	405435000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3024000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	906000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33543000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	114000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	391877000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
	us-gaap	Depreciation Depreciation	6698000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	9752000	usd
	auph	Foreign Translation On Finance Lease Liability ForeignTranslationOnFinanceLeaseLiability	718000	usd
	auph	Foreign Translation On Finance Lease Liability ForeignTranslationOnFinanceLeaseLiability	1335000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-220000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	12394000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	419000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	24463000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8984000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2889000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	16000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11812000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-499000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14274000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	240000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47773000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	461140000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	379213000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	461448000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	391287000	usd
	us-gaap	Payments To Acquire Lease Receivables PaymentsToAcquireLeaseReceivables	11864000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8959000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3929000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26046000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	447000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11733000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47775000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37142000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8327000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	474000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	388002000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	392292000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11808000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	646000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	18619000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	703000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22650000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	345000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	388002000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	405435000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3024000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	906000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33543000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	114000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	391877000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
	us-gaap	Depreciation Depreciation	6698000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	9752000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22650000	usd
	auph	Foreign Translation On Finance Lease Liability ForeignTranslationOnFinanceLeaseLiability	718000	usd
	auph	Foreign Translation On Finance Lease Liability ForeignTranslationOnFinanceLeaseLiability	1335000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1659000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	24463000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2889000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	16000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11812000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47773000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	379213000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	391287000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	419000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	225000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	240000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	39000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18435000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3482000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1348000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3929000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26046000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47775000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48875000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	3559000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1459000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94172000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37142000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	2803000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45557000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	512000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-449000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18435000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8959000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3929000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26046000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	447000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11733000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47775000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37142000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	2803000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	3559000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1459000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	339000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36630000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.25
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	2803000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	3559000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1459000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	339000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	840000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.25
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers:</span> The Company currently has two main specialty pharmacies for U.S. commercial sales of LUPKYNIS and a collaboration partnership with Otsuka for sales of semi-finished product and royalty, collaboration, and manufacturing services revenue in the Otsuka Territories.
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	36500000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	24100000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers:</span> The Company currently has two main specialty pharmacies for U.S. commercial sales of LUPKYNIS and a collaboration partnership with Otsuka for sales of semi-finished product and royalty, collaboration, and manufacturing services revenue in the Otsuka Territories.
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	36500000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	24100000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers:</span> The Company currently has two main specialty pharmacies for U.S. commercial sales of LUPKYNIS and a collaboration partnership with Otsuka for sales of semi-finished product and royalty, collaboration, and manufacturing services revenue in the Otsuka Territories.
	auph	Concentration Risk Number Of Customers ConcentrationRiskNumberOfCustomers	2	segment
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	36500000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	24100000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	350690000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	348700000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	350700000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	348326000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	421000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	348747000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost	348326000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	421000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	350690000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	348700000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	350700000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	311600000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	301800000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	348326000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	421000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	348747000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost	348326000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	421000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses	0	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	1000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	350489000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	75000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses	1000	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	500000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	700000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	500000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	300000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	348700000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	350700000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	301800000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	348326000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	348747000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	421000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	350416000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	1000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	350489000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost	350616000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	75000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses	1000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	350690000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	700000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	500000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	300000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	348700000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	350700000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	311600000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	301800000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	348326000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	421000	usd
	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	348747000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost	348326000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	421000	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses	0	usd
CY2024Q3	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	348747000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	350416000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Gain AvailableForSaleDebtSecuritiesGrossUnrealizedGain	74000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	1000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments	350489000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Amortized Cost CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsAmortizedCost	350616000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Gains CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedGains	75000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments Unrealized Losses CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestmentsUnrealizedLosses	1000	usd
CY2023Q4	auph	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Investments CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndInvestments	350690000	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	500000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	700000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	500000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	300000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	100000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	800000	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1702000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37376000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2022000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	38714000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	39705000	usd
CY2024Q3	auph	Prepaid Assets Current PrepaidAssetsCurrent	7730000	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1896000	usd
CY2024Q3	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	13815000	usd
CY2023Q4	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	9486000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2024Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	34990000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2022000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	38714000	usd
CY2024Q3	auph	Prepaid Assets Current PrepaidAssetsCurrent	7730000	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1896000	usd
CY2023Q4	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	9486000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	800000	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1702000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2022000	usd
CY2024Q3	auph	Prepaid Assets Current PrepaidAssetsCurrent	7730000	usd
CY2023Q4	auph	Prepaid Assets Current PrepaidAssetsCurrent	6892000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20072000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15563000	usd
CY2024Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4189000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1345000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4509000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19846000	usd
CY2024Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1896000	usd
CY2024Q3	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	13815000	usd
CY2023Q4	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	9486000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14869000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4977000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	800000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1746000	usd
CY2024Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	34990000	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2022000	usd
CY2024Q3	auph	Prepaid Assets Current PrepaidAssetsCurrent	7730000	usd
CY2024Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4189000	usd
CY2024Q3	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	13815000	usd
CY2023Q4	auph	Prepaid Expenses And Deposits Current PrepaidExpensesAndDepositsCurrent	9486000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20072000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4509000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19846000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14869000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4977000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20072000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4509000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19846000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14869000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5264000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5264000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2377000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2887000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3354000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20072000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4509000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19846000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14869000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4977000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5264000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5264000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2377000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1910000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2887000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3354000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5264000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2377000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1910000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3354000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	600000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M24D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0527
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0619
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8959000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3482000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3354000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	718000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	805000	usd
	auph	Finance Right Of Use Asset Obtained In Exchange For Lease Obligations FinanceRightOfUseAssetObtainedInExchangeForLeaseObligations	96459000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	80882000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	85521000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	283000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	17203000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1141000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	17204000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1169000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	17204000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5264000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5264000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2377000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1910000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2887000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3354000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0619
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8959000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3354000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	718000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	831000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	805000	usd
	auph	Finance Right Of Use Asset Obtained In Exchange For Lease Obligations FinanceRightOfUseAssetObtainedInExchangeForLeaseObligations	96459000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	85521000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	4295000	usd
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0619
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8959000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3482000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3354000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	718000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	831000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	805000	usd
	auph	Finance Right Of Use Asset Obtained In Exchange For Lease Obligations FinanceRightOfUseAssetObtainedInExchangeForLeaseObligations	96459000	usd
	auph	Finance Right Of Use Asset Obtained In Exchange For Lease Obligations FinanceRightOfUseAssetObtainedInExchangeForLeaseObligations	113069000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	80882000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	85521000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	4295000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	283000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	17203000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1141000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	17204000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1198000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	17205000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1227000	usd
CY2024Q3	auph	Finance Lease Liability To Be Paid Due After Year Four FinanceLeaseLiabilityToBePaidDueAfterYearFour	21554000	usd
CY2024Q3	auph	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3302000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	94665000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8320000	usd
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	13783000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	80882000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14180000	usd
CY2023Q4	auph	Accrued Research Current AccruedResearchCurrent	5503000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	667000	usd
CY2024Q3	auph	Restructuring Accruals Current RestructuringAccrualsCurrent	179000	usd
CY2023Q4	auph	Restructuring Accruals Current RestructuringAccrualsCurrent	0	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56770000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0527
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0619
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8959000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	3354000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	718000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	831000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	805000	usd
	auph	Finance Right Of Use Asset Obtained In Exchange For Lease Obligations FinanceRightOfUseAssetObtainedInExchangeForLeaseObligations	113069000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	80882000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	85521000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	4295000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	283000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	17203000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1141000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1169000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	17204000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	17205000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1227000	usd
CY2024Q3	auph	Finance Lease Liability To Be Paid Due After Year Four FinanceLeaseLiabilityToBePaidDueAfterYearFour	21554000	usd
CY2024Q3	auph	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3302000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	94665000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8320000	usd
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	13783000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1351000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	80882000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14180000	usd
CY2024Q3	auph	Accrued Research Current AccruedResearchCurrent	2331000	usd
CY2023Q4	auph	Restructuring Accruals Current RestructuringAccrualsCurrent	0	usd
CY2023Q4	auph	Accrued Research Current AccruedResearchCurrent	5503000	usd
CY2024Q3	auph	Restructuring Accruals Current RestructuringAccrualsCurrent	179000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56770000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	17203000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1141000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	17204000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1198000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	17205000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1227000	usd
CY2024Q3	auph	Finance Lease Liability To Be Paid Due After Year Four FinanceLeaseLiabilityToBePaidDueAfterYearFour	21554000	usd
CY2024Q3	auph	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3302000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	94665000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8320000	usd
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	13783000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	80882000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6969000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14180000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1007000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	667000	usd
CY2023Q4	auph	Restructuring Accruals Current RestructuringAccrualsCurrent	0	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56770000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	54389000	usd
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	usd
CY2024Q1	auph	Stock Repurchase Program Percentage StockRepurchaseProgramPercentage	0.15
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1198000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	17205000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1227000	usd
CY2024Q3	auph	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3302000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	94665000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8320000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1351000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	80882000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6969000	usd
CY2024Q3	auph	Commercial Related Accruals Current CommercialRelatedAccrualsCurrent	25523000	usd
CY2023Q4	auph	Commercial Related Accruals Current CommercialRelatedAccrualsCurrent	16216000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14180000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22486000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10800000	usd
CY2024Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	8878000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4327000	usd
CY2023Q4	auph	Accrued Research Current AccruedResearchCurrent	5503000	usd
CY2024Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1007000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	667000	usd
CY2024Q3	auph	Restructuring Accruals Current RestructuringAccrualsCurrent	179000	usd
CY2023Q4	auph	Restructuring Accruals Current RestructuringAccrualsCurrent	0	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56770000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10800000	usd
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3400000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	18600000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143051000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142847000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145651000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142847000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145010000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10800000	usd
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	usd
CY2024Q1	auph	Stock Repurchase Program Percentage StockRepurchaseProgramPercentage	0.15
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	18600000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13447000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143051000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145651000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142847000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	usd
CY2024Q1	auph	Stock Repurchase Program Percentage StockRepurchaseProgramPercentage	0.15
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3400000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	18600000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13447000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143051000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143085000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142847000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145010000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	14350000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13447000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-51145000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143051000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	142847000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145651000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145010000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	143085000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0408
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0392
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	auph	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.130
	auph	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.127
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.94
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.63
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.89
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	125000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2006000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.81
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9750000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.09
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8327000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0408
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0392
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	auph	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.127
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.94
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11556000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	325000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.89
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	125000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2006000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.81
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9750000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.09
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8327000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11808000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22650000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33543000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	25700000	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0408
	auph	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.130
	auph	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.127
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.94
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11556000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	325000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.89
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2006000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.81
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.09
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8327000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33543000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	25700000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.77
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0408
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0392
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	auph	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.127
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	0.000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.94
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11556000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	325000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.89
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	125000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2006000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.81
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9750000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.09
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8327000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11808000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22650000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	25700000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22650000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000.0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.25
CY2024Q3	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7800000	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7755000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000.0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2024Q3	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7800000	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7755000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000.0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	usd
CY2024Q1	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.25
CY2024Q3	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7800000	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7755000	usd
CY2024Q3	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7800000	usd
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7755000	usd

Files In Submission

Name	View Source	Status
0001600620-24-000108-index-headers.html	Edgar Link	pending
0001600620-24-000108-index.html	Edgar Link	pending
0001600620-24-000108.txt	Edgar Link	pending
0001600620-24-000108-xbrl.zip	Edgar Link	pending
auph-20240930.htm	Edgar Link	pending
auph-20240930.xsd	Edgar Link	pending
auph-2024q3exx311.htm	Edgar Link	pending
auph-2024q3exx312.htm	Edgar Link	pending
auph-2024q3exx321.htm	Edgar Link	pending
auph-2024q3exx322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
auph-20240930_cal.xml	Edgar Link	unprocessable
auph-20240930_def.xml	Edgar Link	unprocessable
auph-20240930_lab.xml	Edgar Link	unprocessable
auph-20240930_pre.xml	Edgar Link	unprocessable
auph-20240930_htm.xml	Edgar Link	completed
0001600620-24-000108-index-headers.html	Edgar Link	pending
0001600620-24-000108-index.html	Edgar Link	pending
0001600620-24-000108.txt	Edgar Link	pending
0001600620-24-000108-xbrl.zip	Edgar Link	pending
auph-20240930.htm	Edgar Link	pending
auph-20240930.xsd	Edgar Link	pending
auph-2024q3exx311.htm	Edgar Link	pending
auph-2024q3exx312.htm	Edgar Link	pending
auph-2024q3exx321.htm	Edgar Link	pending
auph-2024q3exx322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
auph-20240930_def.xml	Edgar Link	unprocessable
auph-20240930_lab.xml	Edgar Link	unprocessable
auph-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
auph-20240930_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
auph-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AUPH
Aurinia Pharmaceuticals Inc. Stock $auph

2024 Q4 Form 10-Q Financial Statement

#000160062024000108 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUPH Aurinia Pharmaceuticals Inc. Stock $auph

2024 Q4 Form 10-Q Financial Statement

#000160062024000108 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUPH
Aurinia Pharmaceuticals Inc. Stock $auph